[go: up one dir, main page]

CN112409354B - Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof - Google Patents

Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof Download PDF

Info

Publication number
CN112409354B
CN112409354B CN202011535627.9A CN202011535627A CN112409354B CN 112409354 B CN112409354 B CN 112409354B CN 202011535627 A CN202011535627 A CN 202011535627A CN 112409354 B CN112409354 B CN 112409354B
Authority
CN
China
Prior art keywords
pyridine
fluoroimidazo
quaternary ammonium
ammonium salt
chloroimidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011535627.9A
Other languages
Chinese (zh)
Other versions
CN112409354A (en
Inventor
汪静莉
韩伟博
高桂祥
汪海
乔海艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suli Pharmaceutical Technology Jiangyin Co ltd
Original Assignee
Suli Pharmaceutical Technology Jiangyin Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suli Pharmaceutical Technology Jiangyin Co ltd filed Critical Suli Pharmaceutical Technology Jiangyin Co ltd
Priority to CN202011535627.9A priority Critical patent/CN112409354B/en
Publication of CN112409354A publication Critical patent/CN112409354A/en
Application granted granted Critical
Publication of CN112409354B publication Critical patent/CN112409354B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to a synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and an intermediate thereof, which comprises the steps of using 4-chloro-2-aminopyridine as an initial material, cyclizing with 2-chloroacetaldehyde to obtain 7-chloroimidazo [1,2-A ] pyridine, reacting the 7-chloroimidazo [1,2-A ] pyridine with halide to obtain 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt, fluorinating to obtain 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt, and finally removing a protecting group under the action of an acidic substance to obtain the 7-fluoroimidazo [1,2-A ] pyridine. The 7-fluoroimidazo [1,2-A ] pyridine is prepared by the intermediate quaternary ammonium salt, has the advantages of cheap and easily-obtained raw materials, high reactant activity, mild reaction conditions, high yield and low production cost, and is suitable for industrial production.

Description

Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and an intermediate thereof.
Background
7-fluoroimidazo [1,2-A ] pyridines are important intermediates for a number of antiviral drugs. Currently, 7-fluoroimidazo [1,2-a ] pyridine is generally obtained by reacting 2-amino-4-fluoropyridine with 2-chloroacetaldehyde in the prior art, and the synthesis method of the raw material 2-amino-4-fluoropyridine mainly comprises the following two methods:
the method comprises the following steps: patent application No. WO201100790761 reports the preparation of 2-amino-4-fluoropyridine using 2-chloro-4-fluoropyridine as a starting material according to the following reaction scheme.
Figure DEST_PATH_IMAGE001
The second method comprises the following steps: patent application No. CN108440402 reports the preparation of 2-amino-4-fluoropyridine using the following reaction formula, using 4-chloro-2-pyridinecarboxylic acid as starting material.
Figure 668743DEST_PATH_IMAGE002
However, the first method uses a palladium catalyst, has high cost and is not suitable for large-scale production; when the second method uses sodium fluoride for fluorination, the reaction conditions are harsh, and the temperature is 180 DEGoC) Higher, not suitable for scale-up production.
Disclosure of Invention
The invention aims to provide a synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and an intermediate thereof, which has the advantages of short process route, simple and convenient operation, low production cost, no need of silica gel chromatographic purification, avoidance of high-temperature reaction, mild reaction conditions and suitability for industrial production.
The technical scheme adopted by the invention for solving the problems is as follows: a7-fluoroimidazo [1,2-A ] pyridine intermediate having the structure:
Figure 100002_DEST_PATH_IMAGE003
wherein R is benzyl or p-methoxybenzyl, X is Cl or F, X1Is Cl or Br.
The invention further aims to provide a synthesis process of a 7-fluoroimidazo [1,2-A ] pyridine intermediate, which has the following reaction formula:
Figure 100002_DEST_PATH_IMAGE005
the method comprises the following steps:
(1) under the action of alkaline substances, 2-amino-4-chloropyridine is used as a starting material to form a ring with 2-chloroacetaldehyde to obtain the 7-chloroimidazo [1,2-A ] pyridine.
(2) The 7-chloroimidazo [1,2-A ] pyridine reacts with halide to obtain the 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt.
(3) The 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt reacts with a fluorinating reagent to obtain the 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt.
Wherein, the 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt and the 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt are both 7-fluoroimidazo [1,2-A ] pyridine intermediates.
Preferably, the molar ratio of the 2-amino-4-chloropyridine to the 2-chloroacetaldehyde in step (1) is 0.5 to 1: 1, the molar ratio of the basic substance to the 2-amino-4-chloro-pyridine is 1-4: 1.
preferably, in the step (1), the basic substance is one or more of sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, sodium tert-butoxide, potassium tert-butoxide, sodium methoxide, potassium methoxide, triethylamine and diisopropylethylamine.
Preferably, in the step (2), the halide is at least one of benzyl bromide, benzyl chloride, p-methoxy benzyl bromide and p-methoxy benzyl chloride, and the molar ratio of the halide to the 7-chloroimidazo [1,2-A ] pyridine is 1-2: 1.
preferably, the fluorinating agent in the step (3) is at least one of sodium fluoride, potassium fluoride, cesium fluoride and tetramethylammonium fluoride, and the molar ratio of the fluorinating agent to the 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt is 1-5: 1.
preferably, the step (1), the step (2) and the step (3) are all performed in a solvent system, the solvent in the step (1) is at least one of an organic alcohol solvent, an organic amide solvent, an organic ether solvent and acetonitrile, and the solvents in the step (2) and the step (3) are all organic amide solvents.
Preferably, the reaction temperature in the step (1) is 75-80 ℃, the reaction temperature in the step (2) is 80-90 ℃, and the reaction temperature in the step (3) is 90-100 ℃.
Another purpose of the invention is to provide a synthesis process of 7-fluoroimidazo [1,2-A ] pyridine, wherein the reaction formula is as follows:
Figure DEST_PATH_IMAGE007
the method comprises the following synthetic steps:
and (3) removing a protecting group from the 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt at the temperature of 60-80 ℃ under the action of an acidic substance to obtain the 7-fluoroimidazo [1,2-A ] pyridine.
Preferably, the acidic substance is at least one of hydrochloric acid, sulfuric acid, phosphoric acid, trifluoroacetic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid and trifluoromethanesulfonic acid, and the molar ratio of the acidic substance to the 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt is 5-20: 1.
Preferably, the synthesis step is performed in a solvent system, and the solvent is at least one of an organic alcohol solvent, an organic amide solvent, an organic ether solvent and acetonitrile.
More preferably, the organic amide solvent is at least one of N, N-dimethylacetamide, N-dimethylformamide and N-methylpyrrolidone.
Compared with the prior art, the invention has the advantages that:
(1) compared with the prior art, the invention has the advantages that the starting materials are cheap and easy to obtain, expensive heavy metal is not required to be used as a catalyst, and the production cost is low.
(2) The 7-fluoroimidazo [1,2-A ] pyridine intermediate 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt synthesized by the method can be directly put into the next reaction without separation and purification, the production period is obviously shortened, and the yield is high; meanwhile, 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt is used as a raw material to carry out the subsequent synthesis of 7-fluoroimidazo [1,2-A ] pyridine, so that the activity of reactants is increased, and the reaction yield is improved.
(3) The method has the advantages of short process route, simple and convenient operation, no need of silica gel chromatographic purification, avoidance of high-temperature reaction, mild reaction conditions and suitability for industrial production.
Drawings
FIG. 1 is a 1HNMR map of 7-fluoroimidazo [1,2-A ] pyridine in example 1 of the present invention.
Detailed Description
The invention is described in further detail below with reference to the accompanying examples.
As shown in FIG. 1, a 1HNMR map of 7-fluoroimidazo [1,2-A ] pyridine in example 1.
Example 1
(1) Preparation of 7-chloroimidazo [1,2-A ] pyridine
Adding 128g (1.0 mol) of 2-amino-4-chloropyridine, 1.28L of ethanol, 336g (4.0 mol) of sodium bicarbonate and 235g of 50% chloroacetaldehyde aqueous solution into a 3L three-necked bottle with a magnetic stirring device at room temperature, heating to 80 ℃ after the addition is finished, refluxing, and reacting for 2 hours; cooling the reaction to 20-30%oAnd C, concentrating, removing ethanol, sequentially adding water and ethyl acetate, separating liquid, and concentrating an organic phase to obtain 136g of brownish red oily liquid with the yield of 90%.
(2) Preparation of 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt
To a 1L three-necked flask equipped with a magnetic stirrer was added 100g (655 mmol) of 7-chloroimidazo [1,2-A ]]Pyridine, 107g (688 mmol) of p-methoxybenzyl chloride and 500mL of N, N-dimethylformamide are replaced by nitrogen, and the temperature is raised to 90 DEGoC, stirring for 2 hours; and after the reaction is finished, cooling to 20-30 ℃, and directly feeding the reaction solution into the next reaction.
Taking a small amount of separation and purification for characterization, and identifying the nuclear magnetic structure as follows:
1HNMR(DMSO-d6,400MHz) δ ppm 8.56(d,1H),7.90(d,1H),7.72(d,1H),7.42(m,2H),7.16(d,2H),6.82(d,2H),5.96(s,2H),3.80(s,3H)。
(3) preparation of 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt
196g (1.3 mol) of cesium fluoride was added to the reaction solution of the step (2), nitrogen gas was replaced, and the temperature was raised to 100oC, stirring for 1 hour, and cooling to 20-30 ℃ after the reaction is finishedoAnd C, adding water and n-butanol, stirring, separating liquid, and concentrating an organic phase to obtain 280 g of a brown yellow solid with the yield of two steps being 91%.
The nuclear magnetic structure identification results are as follows:
1HNMR(DMSO-d6,400MHz) δ ppm 8.55(d,1H),7.90(d,1H),7.72(d,1H),7.16(d,2H),7.09(m,2H),6.82(d,2H),5.96(s,2H),3.80(s,3H)。
(4) preparation of 7-fluoroimidazo [1,2-A ] pyridines
To a 1L three-necked flask equipped with a magnetic stirrer was added 100g (324 mmol) of 7-fluoroimidazo [1,2-A]Quaternary pyridinium salt and 300mL (4620mmol) methanesulfonic acid, substitutionNitrogen, heating to 80 deg.CoC, stirring for 2 hours, cooling to 20-30 ℃ after the reaction is finishedoC, adding water and ethyl acetate, adjusting the pH of the water phase to 9-10 by using 50% sodium hydroxide, separating the liquid, concentrating the organic phase, and recrystallizing by using ethyl acetate-n-heptane to obtain 35.2g of light yellow solid with the yield of 80%.
The nuclear magnetic identification results are as follows:
1HNMR(DMSO-d6,400MHz) δ ppm 8.00(t,1H),7.52(d,2H),7.19(d,1H),6.61(t,1H)。
example 2
The procedures (1), (2) and (3) are the same as those in example 1.
Step (4) preparation of 7-fluoroimidazo [1,2-A ] pyridine
To a 1L three-necked flask equipped with a magnetic stirrer was added 100g (324 mmol) of 7-fluoroimidazo [1,2-A]Quaternary pyridinium salt and 300mL (3398mmol) of trifluoromethanesulfonic acid, displacing nitrogen, and heating to 80 deg.CoC, stirring for 1 hour, and cooling to 20-30 ℃ after the reaction is finishedoC, adding water and ethyl acetate, adjusting the pH of the water phase to 9-10 by using 50% sodium hydroxide, separating, concentrating the organic phase, and recrystallizing by using ethyl acetate-n-heptane to obtain 36.1g of light yellow solid with the yield of 81%.
Example 3
The procedures (1), (2) and (3) are the same as those in example 1.
Step (4) preparation of 7-fluoroimidazo [1,2-A ] pyridine
To a 1L three-necked flask equipped with a magnetic stirrer was added 100g (324 mmol) of 7-fluoroimidazo [1,2-A]Quaternary pyridinium salt and 400m (5367mmol) trifluoroacetic acid, displacing nitrogen, heating to 70 deg.CoC, stirring for 3 hours, cooling to 20-30 ℃ after the reaction is finishedoC, adding water and ethyl acetate, adjusting the pH of the water phase to 9-10 by using 50% sodium hydroxide, separating the liquid, concentrating the organic phase, and recrystallizing by using ethyl acetate-n-heptane to obtain 34.2g of light yellow solid with the yield of 77%.
In addition to the above embodiments, the present invention also includes other embodiments, and any technical solutions formed by equivalent transformation or equivalent replacement should fall within the scope of the claims of the present invention.

Claims (9)

1. A synthesis process of a 7-fluoroimidazo [1,2-A ] pyridine intermediate is characterized by comprising the following steps: the reaction formula is as follows:
Figure 482495DEST_PATH_IMAGE002
wherein R is benzyl or p-methoxybenzyl, X1Is Cl or Br;
the method comprises the following steps:
(1) under the action of alkaline substances, 2-amino-4-chloropyridine is used as a starting material to form a ring with 2-chloroacetaldehyde to obtain 7-chloroimidazo [1,2-A ] pyridine;
(2) reacting 7-chloroimidazo [1,2-A ] pyridine with halide to obtain 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt;
(3) reacting 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt with a fluorinating reagent to obtain 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt;
wherein, the 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt and the 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt are both 7-fluoroimidazo [1,2-A ] pyridine intermediates.
2. The process of synthesis of a 7-fluoroimidazo [1,2-a ] pyridine intermediate according to claim 1, characterized in that: the molar ratio of the 2-amino-4-chloropyridine to the 2-chloroacetaldehyde in the step (1) is 0.5-1: 1, the molar ratio of the basic substance to the 2-amino-4-chloro-pyridine is 1-4: 1.
3. the process of synthesis of a 7-fluoroimidazo [1,2-a ] pyridine intermediate according to claim 1, characterized in that: in the step (1), the alkaline substance is one or more of sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, sodium tert-butoxide, potassium tert-butoxide, sodium methoxide, potassium methoxide, triethylamine and diisopropylethylamine.
4. The process of synthesis of a 7-fluoroimidazo [1,2-a ] pyridine intermediate according to claim 1, characterized in that: in the step (2), the halide is at least one of benzyl bromide, benzyl chloride, p-methoxy benzyl bromide and p-methoxy benzyl chloride, and the molar ratio of the halide to the 7-chloroimidazo [1,2-A ] pyridine is 1-2: 1.
5. the process of synthesis of a 7-fluoroimidazo [1,2-a ] pyridine intermediate according to claim 1, characterized in that: in the step (3), the fluorinating reagent is at least one of sodium fluoride, potassium fluoride, cesium fluoride and tetramethylammonium fluoride, and the molar ratio of the fluorinating reagent to the 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt is 1-5: 1.
6. the process of synthesis of a 7-fluoroimidazo [1,2-a ] pyridine intermediate according to claim 1, characterized in that: the step (1), the step (2) and the step (3) are all carried out in a solvent system, the solvent in the step (1) is at least one of an organic alcohol solvent, an organic amide solvent, an organic ether solvent and acetonitrile, and the solvents in the step (2) and the step (3) are all organic amide solvents.
7. A synthesis process of 7-fluoroimidazo [1,2-A ] pyridine is characterized by comprising the following steps: the reaction formula is as follows:
Figure DEST_PATH_IMAGE003
wherein R is benzyl or p-methoxybenzyl, X1Is Cl or Br;
the method comprises the following synthetic steps:
removing a protecting group from the 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt under the action of an acidic substance to obtain 7-fluoroimidazo [1,2-A ] pyridine;
wherein the 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt is prepared by the following steps:
Figure DEST_PATH_IMAGE005
wherein R is benzyl or p-methoxybenzyl, X1Is Cl or Br;
(1) under the action of alkaline substances, 2-amino-4-chloropyridine is used as a starting material to form a ring with 2-chloroacetaldehyde to obtain 7-chloroimidazo [1,2-A ] pyridine;
(2) reacting 7-chloroimidazo [1,2-A ] pyridine with halide to obtain 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt;
(3) the 7-chloroimidazo [1,2-A ] pyridine quaternary ammonium salt reacts with a fluorinating reagent to obtain the 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt.
8. The process of synthesizing 7-fluoroimidazo [1,2-a ] pyridine according to claim 7, characterized in that: the acidic substance is at least one of hydrochloric acid, sulfuric acid, phosphoric acid, trifluoroacetic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid and trifluoromethanesulfonic acid, and the molar ratio of the acidic substance to the 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt is 5-20: 1.
9. The process of synthesizing 7-fluoroimidazo [1,2-a ] pyridine according to claim 7, characterized in that: the synthesis step of removing the protecting group of the 7-fluoroimidazo [1,2-A ] pyridine quaternary ammonium salt under the action of an acidic substance to obtain the 7-fluoroimidazo [1,2-A ] pyridine is carried out in a solvent system, and the solvent is at least one of an organic alcohol solvent, an organic amide solvent, an organic ether solvent and acetonitrile.
CN202011535627.9A 2020-12-23 2020-12-23 Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof Active CN112409354B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011535627.9A CN112409354B (en) 2020-12-23 2020-12-23 Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011535627.9A CN112409354B (en) 2020-12-23 2020-12-23 Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof

Publications (2)

Publication Number Publication Date
CN112409354A CN112409354A (en) 2021-02-26
CN112409354B true CN112409354B (en) 2021-10-08

Family

ID=74782461

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011535627.9A Active CN112409354B (en) 2020-12-23 2020-12-23 Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof

Country Status (1)

Country Link
CN (1) CN112409354B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110759827A (en) * 2019-11-07 2020-02-07 江苏索普化工股份有限公司 A kind of method for preparing ethyl acetate by catalytic esterification
CN111635401A (en) * 2020-06-18 2020-09-08 镇江卡博医药科技有限公司 Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method
CN112047942A (en) * 2020-10-26 2020-12-08 都创(上海)医药科技有限公司 Synthesis method of 7-fluoroimidazo [1,2-A ] pyridine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110759827A (en) * 2019-11-07 2020-02-07 江苏索普化工股份有限公司 A kind of method for preparing ethyl acetate by catalytic esterification
CN111635401A (en) * 2020-06-18 2020-09-08 镇江卡博医药科技有限公司 Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method
CN112047942A (en) * 2020-10-26 2020-12-08 都创(上海)医药科技有限公司 Synthesis method of 7-fluoroimidazo [1,2-A ] pyridine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DEALKYLATION OF QUATERNARY 1-ALKYLAZOLO[a]PYRIDINIUM SALTS;L. M. Potikha 等;《Chemistry of Heterocyclic Compounds》;20120531;第48卷(第2期);第351页结构式部分、第353页第3段 *

Also Published As

Publication number Publication date
CN112409354A (en) 2021-02-26

Similar Documents

Publication Publication Date Title
JP5817079B2 (en) Process for preparing 6- (7-((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide, or a pharmaceutically acceptable salt thereof
CN114149427A (en) Synthesis method of non-neferitone and intermediate thereof
CN112409354B (en) Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof
CN113698317A (en) Synthetic method of apatamide, intermediate and synthetic method thereof
US20060069260A1 (en) Preparation of N-aryl pyridones
CN116082361B (en) Method for preparing Marbalo Sha Wei intermediate and Marbalo Sha Wei
CN112174842A (en) Method for preparing (S) -3-amino-2-benzyl propionic acid
CN114751836B (en) Synthesis method and intermediate of 3- (4-methyl-1H-imidazol-1-yl) -5- (trifluoromethyl) aniline
CN117946104A (en) Preparation method of iodine-mediated indolo [2,3-b ] quinoline compound in water phase
CN116375615A (en) Preparation method of florfenicol amine, intermediate thereof and preparation method thereof
CN105294556A (en) Method for preparing montelukast acid
CN108117564B (en) Process method for preparing cryptate 222
CN113999200B (en) A synthesis method of thiodiazaspiro compound, intermediate thereof and synthesis method thereof
CN113683648A (en) A kind of synthetic method of 2'-fluoro-2'-deoxyuridine and intermediate thereof
CN117247348B (en) A preparation method of 3-fluoro-4-aminopyridine
CN103073498A (en) Novel preparation method for (R)-Alpha-amino-e-caprolactam
CN109456285A (en) A kind of preparation method of ranolazine
CN111518148A (en) Synthetic method of gastrodin intermediate
CN110015987B (en) Preparation method of 2,3 '-dimethoxy- [2,4' ] bipyridyl
CN116082351B (en) Synthesis method and application of photoaffinity probe reagent 3- (3-ethanol-3H-biaziridine) propiolactone
CN108689923B (en) A new method for the synthesis of green and practical N,N-lutidine compounds
CN111333528B (en) Synthesis method of multi-configuration O-phenyl-serine compound
CN103787858B (en) Method for preparing 9-fluorenone through fluorene
CN110950865B (en) Synthetic method of medical intermediate 8-chloro-1, 7-naphthyridine-3-formaldehyde
CN110922401B (en) Preparation method of quinuclidone derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant